Elicio Therapeutics (ELTX) Total Non-Current Liabilities (2019 - 2026)
Elicio Therapeutics (ELTX) recorded Total Non-Current Liabilities of $22.28 million in Q2 2026, down 6.7% from $23.87 million a year earlier but up 8.5% from the prior quarter.
Powered by 
Analysis
Elicio Therapeutics (ELTX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Elicio Therapeutics reported Total Non-Current Liabilities of $21.61 million, down 41.1% from FY2024.
- Annual Total Non-Current Liabilities has a four-year compound annual growth rate of -40.4% (FY2021 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $36.66 million in FY2024 (+132.6%), $15.76 million in FY2023 and $171.05 million in FY2021.
- Quarterly Total Non-Current Liabilities has ranged from $11.74 million in Q1 2024 to $171.05 million in Q4 2021 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities rose in four of the last seven quarters, with growth averaging 27.3%.
- Per Business Quant, the preceding three quarters came in at $20.53 million (Q1 2026), $21.61 million (Q4 2025) and $20.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Elicio Therapeutics | 45.57 Mn | -42.34 Mn | - | 20.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.34 Mn |
| Jun 30, 2026 | 22.28 Mn |
| Mar 31, 2026 | 20.53 Mn |
| Dec 31, 2025 | 21.61 Mn |
| Sep 30, 2025 | 20.59 Mn |
| Jun 30, 2025 | 23.87 Mn |
| Mar 31, 2025 | 16.28 Mn |
| Dec 31, 2024 | 36.66 Mn |
| Sep 30, 2024 | 34.19 Mn |
| Jun 30, 2024 | 13.15 Mn |
| Mar 31, 2024 | 11.74 Mn |
| Dec 31, 2023 | 15.76 Mn |
| Sep 30, 2023 | 17.68 Mn |
| Jun 30, 2023 | 14.03 Mn |
| Mar 31, 2023 | 151.63 Mn |
| Dec 31, 2022 | 124.81 Mn |
| Sep 30, 2022 | 156.99 Mn |
| Jun 30, 2022 | 159.35 Mn |
| Mar 31, 2022 | 162.47 Mn |
| Dec 31, 2021 | 171.05 Mn |
API Access
Elicio Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ELTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ELTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ELTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();